Is Angi, Inc. overvalued or undervalued?

As of 7 November 2025, the valuation grade for Angi, Inc. has moved from expensive to fair. Based on the current metrics, Angi appears to be fairly valued. Key ratios include a P/E ratio of 16, a Price to Book Value of 0.81, and an EV to EBITDA of 8.45. In comparison to peers, Angi's P/E ratio of 14.77 is more attractive than Sharecare, Inc. which is risky with a P/E of -5.08, and GoodRx Holdings, Inc. which is fair with a P/E of 31.76.
While specific return data is not available, the overall valuation suggests that Angi, Inc. is positioned reasonably within its industry, especially when compared to its peers.